NASDAQ: CIRCCircle8 Group Inc Stock
$0.60-0.06 (-9.09%)
Updated Sep 8, 2026
CIRC Price
$0.60
Fair Value Price
N/A
Market Cap
$69.10M
52 Week Low
$0.41
52 Week High
$5.20
P/E
-0.29x
P/B
-2.71x
P/S
0.09x
PEG
N/A
Dividend Yield
N/A
Revenue
$799.87M
Earnings
-$155.08M
Gross Margin
8.6%
Operating Margin
-17.86%
Profit Margin
-19.4%
Debt to Equity
-38.67
Operating Cash Flow
-$23M
Beta
0.63
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CIRC Overview
SeqLL Incorporated is a life sciences instrumentation and research services company focused on the manufacture of genetic analysis technologies. It offers a True Single Molecule Sequencing (tSMS) platform (a single molecule solution for DNA and RNA sequencing). The company has positioned itself to address gaps left by standard sequencing technologies in RNA transcriptome analysis and specialty DNA analysis. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is headquartered in Billerica, MA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CIRC's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -6.47% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Staffing & Employment Service
Industry Rating
B
CIRC
Ranked#16 of 17
Ranked#16 of 17
Be the first to know about important CIRC news, forecast changes, insider trades & much more!
CIRC News
Overview
Due Diligence Score
–
Industry Average (35)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CIRC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CIRC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CIRC is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
CIRC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more CIRC due diligence checks available for Premium users.
Valuation
CIRC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.29x
Industry
21.86x
Market
41.18x
CIRC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-2.71x
Industry
8.44x
CIRC's financial health
Profit margin
Revenue
$319.8M
Net Income
-$86.4M
Profit Margin
-27%
CIRC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CIRC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$965.6M
Liabilities
$987.6M
Debt to equity
-38.67
CIRC's short-term liabilities ($842.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CIRC's short-term assets ($330.76M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CIRC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CIRC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.8M
Investing
-$40.0k
Financing
-$1.9M
CIRC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CIRC vs Staffing & Employment Service Stocks
Circle8 Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.